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Development of glandular organs such as the kidney, lung, and prostate involves the process of branching morphogenesis.
The developing organ begins as an epithelial bud that invades the surrounding mesenchyme, projecting dividing epithelial
cords or tubes away from the site of initiation. This is a tightly regulated process that requires complex epithelial–
mesenchymal interactions, resulting in a three-dimensional treelike structure. We propose that activins are key growth and
differentiation factors during this process. The purpose of this review is to examine the direct, indirect, and correlative lines
of evidence to support this hypothesis. The expression of activins is reviewed together with the effect of activins and
follistatins in the development of branched organs. We demonstrate that activin has both negative and positive effects on
cell growth during branching morphogenesis, highlighting the complex nature of activin in the regulation of proliferation
and differentiation. We propose potential mechanisms for the way in which activins modify branching and address the issue
of whether activin is a regulator of branching morphogenesis. © 2001 Academic Press
Key Words: branching morphogenesis; organogenesis; embryogenesis; activin; inhibin; follistatin; TGFb; epithelium;
mesenchyme; stroma.INTRODUCTION
Activins and inhibins are members of the TGFb super-
family that regulate growth and differentiation via both
autocrine and paracrine mechanisms. They perform diverse
roles in different tissues and often have opposing effects.
Activins were originally isolated as gonadal regulators of
follicle-stimulating hormone (Ling et al., 1986), although
mesoderm induction was the first main role identified for
activin during development (Albano et al., 1990; Smith et
al., 1990; Thomsen et al., 1990; van den Eijnden-Van Raaij
et al., 1990; Mishina et al., 1995; Oda et al., 1995; Gu et al.,
998; Weinstein et al., 1998). More recently, roles for
ctivins were identified in bone morphogenesis (Merino et
l., 1999), the establishment of both anteroposterior and
eft–right axes (Mitrani et al., 1990; Thomsen et al., 1990;
ondo et al., 1991; Mathews et al., 1992; Oda et al., 1995;
h and Li, 1997; Nomura and Li, 1998; Waldrip et al., 1998;
Song et al., 1999; Kim et al., 2000), and branching morpho-
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All rights of reproduction in any form reserved.genesis of glandular organs (references in relevant sections
below).
The purpose of this review is to examine the evidence
that supports the hypothesis that these growth factors
modulate branching morphogenesis in the kidney, prostate,
and other branched organs. The overview of this topic is
necessarily concise and the reader is directed to key refer-
ences for more detailed information. The patterns of cell–
cell interactions during development and the expression of
activin-signaling components are compared in different
branched organs. Evidence that activins have functional or
biological effects (blocking endogenous activin action or
addition of exogenous activins) is examined. Finally, the
impact of knockout and transgenic models on elucidating
the action of activin signaling in vivo during embryogenesis
and organogenesis is reviewed.
ACTIVIN BIOLOGY
Activins and inhibins are dimeric proteins (Fig. 1). Ac-
tivin consists of two b subunits, bA and bB, that form the
hetero- or homodimers, activin A (bA:bA), activin B (bB:
bB), or activin AB (bA:bB). Inhibin consists of an a subunit
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2 Ball and Risbridgerthat dimerizes with one of the activin b subunits to form
either inhibin A (a:bA) or inhibin B (a:bB). Three other b
subunits (bC, bD, and bE) have the potential to form new
ctivins and inhibins (Hotten et al., 1995; Oda et al., 1995;
Fang et al., 1996) but the existence of all the possible dimer
combinations remains to be confirmed. Activin bC subunit
id not dimerize with the a subunit to form inhibin C in
vitro (a:bC), although it dimerized with the other b sub-
nits, bA and bB (Mellor et al., 2000).
Activins signal through membrane-bound receptors as
hown in Fig. 2 (see recent reviews: Heldin et al., 1997;
atto and Wang, 2000; Itoh et al., 2000; Miyazono, 2000;
einstein et al., 2000; Wrana and Attisano, 2000). The
ctivin receptors share homology with the receptors for
ther TGFb-superfamily ligands. In vitro studies demon-
strated an interaction between the activin ligands and
activin receptors and between the TGFb ligands and TGFb
receptors. Bone morphogenetic proteins (BMPs) signal
through activin receptors (Yamashita et al., 1995) and
activin and TGFb receptor subunits form complexes in
itro (ten Dijke et al., 1994), making it difficult to predict
he outcomes and significance of ligand bioactivity. Fur-
hermore, because the pathways converge, it is theoreti-
ally possible that different ligands signal through the same
et of Smads, resulting in the same bioactivity. However,
ubtle discrete differences in the recruitment and activation
f different receptors and Smads lead to distinct biological
ctivities (Dennler et al., 1998; Labbe et al., 1998; Dennler
et al., 1999; Zhu et al., 1999). It remains to be determined
how the different combinations of ligands, receptors, and
Smad proteins lead to distinct biological effects and
whether there are some combinations that lead to the same
biological outcomes. One of the key features to distinguish
activin signaling from TGFb and other members of the
FIG. 1. Schematic diagram of activin and inhibin dimers. Activin
isoforms consist of two b subunits linked by disulfide bonds. The
nomenclature of activin dimers is such that bA:bA is designated
ctivin A, bB:bB is activin B, and bA:bB is activin AB. Inhibin
soforms consist of a common a subunit linked to a b subunit. The
ability of bC, bD, or bE subunits to dimerize with other b or a
subunits is currently unknown.superfamily is that activin ligand access to the receptors
Copyright © 2001 by Academic Press. All rightcan be blocked by follistatin (FS) or inhibin (Nakamura et
al., 1990; Xu et al., 1995; de Winter et al., 1996; Iemura et
al., 1998). The issue of activin binding proteins such as
follistatin is another complicating factor and, in interpret-
ing the data described in this review, one must also bear in
mind that follistatin can also bind other members of the
TGFb superfamily such as the BMPs, albeit at much lower
ffinity than that of activin (Fainsod et al., 1997; Iemura et
l., 1998). The interaction between follistatin and activin
as a significant effect on the biological action of activin.
Follistatins are glycoproteins that bind activins, neutral-
zing their activity. Follistatins are highly conserved be-
ween species and are structurally unrelated to the activin
nd inhibin subunits (Phillips and de Kretser, 1998). Differ-
ntial mRNA splicing generates several functional iso-
orms, such as the ECM-bound FS-288 and the secreted
S-315 (Sugino et al., 1993). Another associated protein,
ollistatin-related protein (FSRP), was shown to bind activin
FIG. 2. Schematic diagram of activin signaling. The extracellular
activin ligand binds to the activin type II (ActRII A or B) receptor.
The activin type I (ActRI A or B) receptor is recruited and phos-
phorylated by the ActRII. This then triggers a signaling cascade
mediated by intracellular Smad proteins. After phosphorylation of
ActRI, Smad-2 or Smad-3 (pathway-restricted, receptor-regulated
Smads or R-Smads) bind to the type I receptor in the cytoplasm and
are phosphorylated. Heteromeric complexes consisting of two
types of Smads are formed. They then bind Smad-4 (common Smad
or Co-Smad) and translocate with Smad-4 to the nucleus. The
nuclear Smad complex binds to Fox HI (Fast-1) DNA-binding
protein forming an “activin-responsive factor” (ARF). The ARF
binds to activin-response elements (AREs) in promoters to regulate
activin-responsive genes.
s of reproduction in any form reserved.
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3Activins and Branching Morphogenesisand was localized to the nuclear membrane (Prof. Alan
Schneyer, personal communication) but its function is
currently unknown.
ACTIVINS AND BRANCHING
MORPHOGENESIS
Branching morphogenesis is a distinctive process that
follows a repetitive pattern common to branched glandular
organs. Organogenesis of branched glandular organs begins
by the budding of preexisting epithelial structures into the
surrounding mesenchyme. Arborization of glandular epi-
thelia occurs by bifurcation of termini, producing two tips
and to a lesser extent, by formation of new branches from
the shaft of older established branches (reviewed in Davies
and Davey, 1999). During branching, differentiation and
ductal canalization occur in a proximal-to-distal manner.
Signals from the mesenchyme initiate and modulate
branching events in the developing gland. Branching is a
highly complex three-dimensional process that is tightly
regulated by cell–cell communications, cell–matrix inter-
actions, and signal transduction pathways, resulting in the
ordered fate-determination, remodeling, proliferation, and/or
differentiation of specific cell populations. Opposing gradi-
ents of inhibitory and stimulatory growth factors are pos-
tulated to tightly regulate branching. Geometric features
such as the length along the ducts, the angle of branching,
and the number of branches are all highly coordinated.
Subtle alterations in any of these features would have
profound effects on the final number of ducts, the spatial
organization, and the overall shape and function of the fully
developed organ.
The importance of activin action during mesoderm in-
duction, bone morphogenesis, and left–right asymmetry
formation is consistent with previous studies showing that
activins are pleiotrophic proteins with diverse effects over a
range of tissues. Activins are key molecules required during
early embryogenesis and organogenesis, where they provide
information to cells on their spatial position and develop-
mental fate. Given activin’s role in spatial organization
during development, and by analogy to other members of
the TGFb superfamily, activin is a candidate factor for a
role in regulating the formation of complex branched or-
gans. In Drosophila larvae, the development of the highly
ranched tracheal system is regulated by activin/TGFb. In
this system the activin/TGFb homologue, decapentaplegic
Dpp), signals through its receptor, thickveins (tkv). Dpp
ontrols cell migration out of the tracheal placode followed
y formation of the tracheal system, independent of its role
n embryonic patterning (reviewed in Hogan and Yingling,
998; Metzger and Krasnow, 1999). The indirect, direct, and
orrelative lines of evidence that activin is involved in more
omplex mammalian branching morphogenesis are dis-
ussed below. For clarity, each organ is considered sepa-
ately, followed by general discussion of the evidence for
Copyright © 2001 by Academic Press. All rightrole of activin as a universal regulator of branching
orphogenesis.
Kidney
Signaling between the metanephric mesenchyme and the
ureteric bud induces kidney development. The ureteric bud
forms as an outgrowth from the Wolffian duct [embryonic
day (ED) 11 in the mouse] (Barasch et al., 1997). For recent
reviews on collecting duct morphogenesis see Davies and
Davey (1999), Pohl et al. (2000b), and http://cpmcnet.
columbia.edu/dept/genetics/kidney/ for time-lapse movies
of ureteric bud growth of in vitro organ cultures (Srinivas et
al., 1999).
The strongest evidence for a role of activins in branching
morphogenesis emerged from studies in the kidney. Activin
is expressed during kidney development, in vitro it reduces
branching of kidney explants, and in vivo disruption of
ActRII caused a range of renal abnormalities. In the devel-
oping kidney, several components of the activin-signaling
pathway are expressed: the bA and bB subunits, the type II
ctivin receptors, and follistatin (Hilden et al., 1994; Rob-
rts and Barth, 1994; Tuuri et al., 1994; Ritvos et al., 1995).
ndirect evidence demonstrated that blocking activin action
nduced branching tubulogenesis in Madin–Darby canine
idney (MDCK) cells, with either transfection of a
ominant-negative ActRII or addition of exogenous follista-
in (Kojima et al., 2001). Further, mouse kidney rudiments
ultured in the presence of activin showed delayed ureteric
pithelial branching: the distances between branches and
he number of secondary branches were diminished (Ritvos
t al., 1995). Follistatin inhibited the effect of activin but
nhibin A had no effect on branching in kidney explants
Ritvos et al., 1995). This illustrates the importance of the
nterplay between activin ligand and follistatin binding
rotein, rather than between activin and inhibin ligands
uring branching.
The mechanism of action of activin A during kidney
evelopment involves other growth factors, for example,
epatocyte growth factor (HGF). HGF is required for the
nitial budding event and branching. Following treatment
ith HGF in vitro, branching tubulogenesis was stimulated
y downregulation of activin A (Maeshima et al., 2000b).
his effect was blocked by follistatin. Although activin A is
onsidered a downstream effector of HGF, the details of the
ascade are unknown.
Data generated in vivo support the in vitro data that
demonstrate an inhibition of branching morphogenesis by
activin. Mice expressing a dominant-negative ActRII, pre-
venting activin signaling, displayed an increase in the
number of glomeruli in vivo (Maeshima et al., 2000a).
Overall, in the kidney there is reasonable evidence that
activin is expressed during the development of the organ,
that it has a biological effect both in vitro and in vivo, and
that its mechanism may involve other growth factors such
as HGF.
s of reproduction in any form reserved.
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4 Ball and RisbridgerProstate
Development of the rodent prostate begins late in gesta-
tion when epithelial budding occurs as a result of intercell
signaling in the urogenital sinus between the mesenchyme
and epithelium (Sugimura et al., 1986; Hayashi et al., 1991;
Timms et al., 1994). Initiation of budding in the developing
prostate is androgen regulated (Cunha et al., 1987, 1995;
Donjacour and Cunha, 1988) but because androgen recep-
tors are located in the mesenchyme, the epithelium re-
sponds indirectly via stromal signals (Cunha, 1972; Cunha
and Young, 1991; Takeda and Chang, 1991). Candidate
factors responsible for signaling events between the epithe-
lium and mesenchyme include members of the FGF and
TGFb superfamily. Evidence of a role for activins in pros-
tatic development is preliminary.
Activin production in the adult prostate is androgen
regulated (Risbridger et al., 1996); it is not known whether
activin synthesis is androgen regulated during develop-
ment. Whereas the adult prostate produces a, bA, and bB
ubunits, during development bB or a subunit production is
egligible (Cancilla et al., 2001). The activin bA subunit
was localized to the undifferentiated mesenchymal cap
adjacent to prostatic epithelium (Cancilla et al., 2001),
consistent with a role for activin A ligand in branching
morphogenesis. Functional studies in which activin A was
added to cultured prostatic explants in the presence and
absence of testosterone showed an inhibition of branching
morphogenesis (Cancilla et al., 2001). Fewer branches de-
veloped and epithelial tips and surrounding mesenchyme
were expanded.
Although activin expression and action in vitro were
demonstrated during branching morphogenesis of the pros-
tate, there are currently no data to implicate inhibins. In
contrast, the activin-binding proteins (follistatins) are pow-
erful modulators of activin action. Follistatin induced pro-
liferation and branching of the organ as well as differentia-
tion of smooth muscle surrounding the epithelial ducts
(Cancilla et al., 2001). Therefore the interplay between
activin and follistatin, rather than activin and inhibin, is
implicated in these studies on prostate, similar to those in
kidney.
There are several mouse models to study the effects of a
disruption of activin signaling, for example, the bA subunit
and activin receptor knockout models and mice expressing
dominant-negative activin receptors (Matzuk et al., 1995a,
b; Song et al., 1999; Maeshima et al., 2000a). No prostate
henotypes were reported in these models, suggesting that
rostate development occurred, but either phenotypic alter-
tions do not exist or closer examination is required to
etermine whether the number of branches, length of
ranches, and other features of prostate growth are changed.
t this stage the detailed studies necessary to identify these
hanges have not yet been performed.
Therefore, in the prostate, the expression and in vitro
ata provide preliminary evidence of a role for activins
uring development. Whether the mechanism of activin a
Copyright © 2001 by Academic Press. All rightction in the prostate is similar to that in the kidney is
nknown.
Mammary Gland
Mammary gland development begins with the extension
of a duct from the nipple. Branching increases dramatically
with the onset of ovarian function. Unlike other organs
discussed in this review, full development of the rodent
mammary gland occurs later in life; however, the processes
are similar to those witnessed in other ductal organs (re-
viewed in Silberstein, 2001). Hormones such as glucocorti-
coids, progesterone, estrogen, prolactin, and other factors
are required for mammary alveolar outgrowth (Topper and
Freeman, 1980). The localization of activins to the develop-
ing mammary gland is largely unknown, but a role for
activins is implied because the adult gland and some
mammary epithelial cell lines expressed activin and activin
receptors types I, II, and IIB (Ying et al., 1995; Liu et al.,
1996; Ying and Zhang, 1996). Functional studies demon-
strated that addition of exogenous activin A inhibited
HGF-induced growth of mammary epithelial and tubule
formation (Liu et al., 1996). Although there are very little
data on the role of activins, preliminary studies reveal an
association between activin A and HGF in mammary de-
velopment. The question remains as to whether this para-
digm is similar to that of the kidney.
The in vivo studies using transgenic mice with various
deletions of genes involved in activin signaling implicate
activins in the branching morphogenesis of mammary epi-
thelium. Rather than demonstrating a role in inhibition of
branching morphogenesis, tissue recombination techniques
demonstrated a requirement for activin in mesenchyme.
Mice lacking the activin bB subunit showed abnormal
mammary ductal elongation and alveolar morphogenesis
during puberty and pregnancy (Robinson and Hen-
nighausen, 1997). Therefore in mammary development, the
inhibitory role of activin A in vitro contrasts with the
apparent requirement for the bB subunit in vivo. One
xplanation for the discrepancy may lie in the multiple
oles of individual activin subunits in forming different
ctivin and inhibin dimers (Fig. 1).
Lung
Murine lung development commences with the primary
lung buds budding from the ventral foregut at ED9.5 fol-
lowed by dichotomous branching events. Localization of
activin and its downstream effectors suggests a role of
activin in lung development. Activin bA and ActRIIB
RNAs were expressed in rat bronchiole tubes, whereas
ollistatin was expressed in the mesenchyme (Roberts and
arth, 1994). Similarly, in the baboon lung, type I and II
ctivin receptor transcripts were expressed and develop-
entally regulated (Zhao et al., 1996). In mouse, both ActRI
nd RIB were highly expressed (Verschueren et al., 1995)
nd Smads -2, -3, and -4 were detected predominantly in the
s of reproduction in any form reserved.
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5Activins and Branching Morphogenesisdistal epithelium (Zhao et al., 1998). Abrogation of Smads
-2 and -3 together, and Smad-4 alone, stimulated lung
branching morphogenesis in culture, resulting from block-
ade of activin and/or TGFb ligand signaling (Zhao et al.,
1998). Functional data generated in embryonic rat lung
explants suggested that TGFb, rather than activin A, regu-
ated pattern formation in the developing rat lung because
ctivin A had no effect in this system (Liu et al., 2000).
owever, activin A stimulated fibroblast proliferation and
ifferentiation in human lung fibroblasts (HFL1 cells) by
timulating a-smooth muscle actin expression (Ohga et al.,
1996). Under three-dimensional culture conditions, activin
A enhanced fibroblast-mediated contraction, the effect of
which was abolished by follistatin (Ohga et al., 2000). These
data imply a role for activin A in pulmonary connective
tissue morphogenesis.
In vivo, mice deficient in follistatin were defective in
lung function, although the specific details of this abnor-
mality are unknown (Matzuk et al., 1995c). Alone, the in
ivo effects of follistatin deficiency do not rule out an effect
ia BMPs and in vitro it is difficult to distinguish between
he effect of TGFb and activin by altering Smad function.
However, follistatin does not interact with TGFb, and
MPs signal through a different set of Smads. Therefore,
verall the data do not exclude activin in lung morphogen-
sis, as demonstrated by the in vitro studies using activin A.
Pancreas
Pancreas development begins with specification of the
foregut endoderm followed by the budding of digestive tract
epithelium. The pancreas consists of two main compo-
nents, the endocrine islet cells (secreting internally into the
circulation) and exocrine acini (secreting outwardly via a
lumen). Transcripts of the type II activin receptor and both
bA and bB activin subunits were detected in the developing
human pancreas (Hilden et al., 1994; Tuuri et al., 1994). In
the rat, activin A protein was detected in primitive islet
cells (Furukawa et al., 1995) and in the mouse, bB, ActRI,
ctRII, and ActIIRB mRNA were localized to the pancreatic
pithelium and islet cells (Ritvos et al., 1995; Yamaoka et
al., 1998; Maldonado et al., 2000). Initially, follistatin was
expressed in the mesenchyme and later downregulated in
the murine pancreas (Miralles et al., 1998; Maldonado et al.,
2000).
In cultured pancreatic rudiments in vitro differentiation
of exocrine components occurred in the presence of mesen-
chyme, whereas in epithelial rudiments cultured in the
absence of mesenchyme, differentiation of endocrine cells
was favored (Miralles et al., 1998). In vitro activin A
inhibited branching and elongation of epithelia in cultured
mouse pancreatic rudiments, blocking development of the
exocrine pancreas. Follistatin alone did not affect the
branching process but counteracted the effects of activin
(Ritvos et al., 1995). In epithelial rudiments cultured in the
absence of mesenchyme, exogenous follistatin mimicked
the effect of mesenchyme by inducing exocrine and repress-
Copyright © 2001 by Academic Press. All righting endocrine development (Miralles et al., 1998). Alto-
gether, the pattern of expression and the functional studies
show that follistatin blocks activin and hence allows exo-
crine differentiation while suppressing endocrine differen-
tiation. Later, the subsequent downregulation of follistatin
allowed activin-mediated endocrine cell differentiation and
formation of islets.
In vivo a requirement for activin in endocrine pancreatic
development is implied because two independently gener-
ated mouse models expressing a dominant-negative ActRII,
blocking activin signaling, showed evidence of pancreatic
islet hypoplasia and various abnormalities of endocrine
cells (Yamaoka et al., 1998; Shiozaki et al., 1999). In mice
expressing the transgene in all cell types, the exocrine
epithelial acinar cells were disrupted (Shiozaki et al., 1999);
therefore, there was consistency between the in vivo and in
vitro data that demonstrated inhibition of pancreatic
branching morphogenesis and development. As in the kid-
ney, there is reasonable evidence that activin is expressed in
the pancreas during development and that it has a biological
effect both in vitro and in vivo.
Salivary Gland
The salivary gland develops with budding of the epithe-
lium into surrounding mesenchyme in a manner similar to
that of other glandular organs. Expression of activin bA and
bB was detected in the developing human, mouse, and rat
salivary gland (Tuuri et al., 1994; Ritvos et al., 1995; Blauer
et al., 1996). In the mouse, expression of the activin bA
subunit was further localized to the smooth muscle cells
and in the rat, it was expressed in the ductal cells (Ritvos et
al., 1995; Blauer et al., 1996). It is not clear whether these
differences in localization reflect interspecies variation,
differences in the detection techniques, or the time of
investigation. Follistatin mRNA was expressed in human
salivary gland (Tuuri et al., 1994): FS protein was localized
to mouse mesenchymal cells surrounding the branching
acinar epithelia as well as to the epithelium itself (Ritvos et
al., 1995). ActRII mRNA was detected in human, mouse,
and rat (Hilden et al., 1994; Roberts and Barth, 1994; Ritvos
et al., 1995) and ActRIB in mouse (Verschueren et al., 1995),
although the location of the receptors themselves is not yet
known. Activin A inhibited salivary gland branching mor-
phogenesis (Ritvos et al., 1995). Specifically, rudiments of
embryonic mouse salivary gland showed fused adenomeres
and disappearance of interlobular clefts, so that globular
bulges appeared in individual lobules after treatment with
activin A (Ritvos et al., 1995). Abnormalities in salivary
gland function or appearance in vivo have not been reported
using any of the animal models with perturbations in
activin signaling. Therefore, as in the prostate, there is
preliminary evidence that elements of the activin-signaling
pathway are present and activin A has an inhibitory effect
in vitro, but little else in known.
s of reproduction in any form reserved.
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Based on the data reviewed in the preceding sections, we
conclude that there is sufficient evidence for a role of
activins in branching morphogenesis. The activin subunits
or proteins are expressed at appropriate times and locations
during branching and, in many instances, there are func-
tional data to demonstrate that activins regulate branching
morphogenesis. Limited studies from knockout mice show
functional consequences of targeted disruption of activin
and associated signaling pathways. However, these results
cannot be consolidated into a single concept or effect of
activins on branching morphogenesis in general.
In terms of the localization and expression of activins in
each of the organs considered in this review, there was no
obvious pattern whereby expression was restricted to epi-
thelia or mesenchyme. Instead, several studies reported
activin subunit and follistatin expression in both cell types.
There was an apparent predominance of activin bA subunit
xpression in prostate and lung epithelia, whereas bB was
the main activin subunit expressed in salivary and pancre-
atic epithelia. Follistatin expression was detected in both
epithelia and mesenchyme and there was a common lack of
inhibin a subunit expression in branched organs. The
patterns of expression were consistent with functional data
and emphasized the interplay between activin and follista-
tin, rather than between activin and inhibins.
The functional in vitro experiments yielded consistent
results across most organs studied. The addition of exog-
enous activin A inhibited branching morphogenesis and
both ductal branch formation and elongation were reduced,
suggesting that activin acted to constrain the degree of
branching and govern the final number and three-
dimensional structure of the ducts (Maeshima et al., 2000a).
A notable exception to these findings was lung, in which
activin A stimulated branching morphogenesis (Ohga et al.,
1996, 2000). Almost exclusively, activin A was the ligand
used in these studies and little is known about the effects of
the other activin homo- or heterodimers. It would be
appropriate to compare the effects of activin A with activin
B and AB, especially in pancreas and salivary gland where
localization data implicate bB subunit homo- or het-
erodimeric ligands (Ritvos et al., 1995; Blauer et al., 1996;
Maldonado et al., 2000) and to determine whether other
activin dimers stimulate branching in the lung as reported
for activin A. Generally, follistatin blocked the effects of
activin A but the effects of other activin-binding proteins,
for example FSRP, are unknown and require examination to
determine whether the interplay between activin and fol-
listatin includes other binding proteins. The functional
consequences of targeted disruption of elements of the
activin-signaling pathway in vivo showed abnormalities
consistent with an inhibitory role for activins as shown in
vitro, at least in the kidney and pancreas. In other organs
the consistency between in vivo and in vitro studies was
not determined because the mouse models were not exam-
Copyright © 2001 by Academic Press. All rightined in sufficient detail or were embryonic lethal (Sirard et
al., 1998; Weinstein et al., 1998).
The construction of new mouse models will contribute to
this area of knowledge. The use of technologies such as the
cre-lox system with temporal and tissue-specific promoters
will enable dissection of the effects of reducing or increas-
ing expression of the gene of interest and overcome the
problems associated with the embryonic lethality of some
of the existing models (Sirard et al., 1998; Weinstein et al.,
1998). Complex breeding strategies between existing mod-
els will enable dissection of multifaceted phenotypes and
eliminate problems associated with redundancy between
proteins.
Better tools of analysis will also contribute to the genera-
tion of data from existing and future animal models. As-
sessment of subtle phenotypic changes in animal models
was hindered by a lack of adequate description of the
“normal” developmental pattern of branching organs. This
requires construction of detailed three-dimensional spatio-
temporal maps. Confocal microscopy of whole-mounted
microdissected tissues can be used to digitally reconstruct
and analyze three-dimensional structures. The digital im-
ages can be converted to numerical data and mathematical
algorithms of branched organs constructed to allow docu-
mentation and comparison of features such as branch
number or duct diameter. Lack of appropriate techniques of
analysis may also explain, at least in part, why so few
changes in branching morphogenesis were detected in the
branched organs from animal models carrying defects in the
activin-signaling pathway.
Limited studies described upstream regulators and down-
stream effectors of activin A in different branched organs.
Activin A did not induce apoptosis in the developing
kidney, pancreas, salivary gland, or prostate (Ritvos et al.,
1995; Cancilla et al., 2001), although the mechanisms by
which activin inhibited branching morphogenesis are
speculative. There is insufficient information regarding
factors that regulate activin A synthesis and action. Using
the kidney and prostate as examples, a preliminary model
for the action of activin A in branching of these organs is
presented in Fig. 3. In the kidney, and perhaps the mam-
mary and salivary glands, activin A acted downstream of
HGF signaling through its receptor c-met and was down-
regulated by HGF during branching (Santos et al., 1994;
Woolf et al., 1995; Liu et al., 1996; Sato and Takahashi,
1997; Furue et al., 1999; Maeshima et al., 2000b). In lung
and prostate, retinoic acid (RA) inhibited branching (Car-
doso et al., 1995; Aboseif et al., 1997; Oshika et al., 1998;
Mollard et al., 2000) and activin A was postulated to act
downstream of RA signaling because both ActRIIA and
ActRIIB were upregulated by RA (Wan et al., 1995;
Ameerun et al., 1996). Other factors such as FGFs (Green et
al., 1992; Ferguson et al., 1998) and androgens (Risbridger et
al., 1996) were also upstream regulators of activin A ligand
in at least some organs. Whether these pathways operate
during branching morphogenesis and whether these factors
s of reproduction in any form reserved.
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7Activins and Branching Morphogenesisregulate other activin ligand levels remains to be estab-
lished.
Little is known about the downstream effectors of activin
ligands during branching morphogenesis. Sonic hedgehog
(Shh) is a secreted signaling factor involved in patterning
and in development, and its expression was downregulated
by activin receptor-mediated signaling (Kim et al., 2000)
nd by activin bB ligand subunit (Hebrok et al., 1998). Shh
was required for development and branching of the prostate
and lung (Pepicelli et al., 1998; Podlasek et al., 1999) but
nhibited pancreatic development and endocrine differen-
iation (Hebrok et al., 2000; Kim et al., 2000). Overall, these
ata implied that Shh acted downstream from activin but
he nature of its role in branching morphogenesis is not
onsistent across the different organs and may be influ-
nced by the predominant activin subunit expressed in each
rgan.
A feature of branching morphogenesis is the extensive
emodeling of extracellular matrix (ECM) involving matrix
eposition and specific disruption of matrix surrounding
udding tips (Hisaoka et al., 1993; Fata et al., 1999; Pohl et
l., 2000a). At the bud tips and alongside the basement
embrane, epithelial cells contact the mesenchymal ECM.
he ECM provides the necessary scaffold along which
ranching normally occurs and therefore a nonspecific
FIG. 3. Schematic diagram showing the process of branching mo
model is based on the current evidence that activins are involved i
bud invades the surrounding mesenchyme, which condenses to form
cap and bifurcation of the epithelial ducts. We propose that acti
hepatocyte growth factor (HGF), fibroblast growth factors (FGF), re
or mesenchymal expansion via ECM remodeling, depending on th
result from either the direct effects of activins or indirectly via regisruption of the matrix inhibited branching (Sorokin et al.,
Copyright © 2001 by Academic Press. All right990; Falk et al., 1996; Kadoya et al., 1997). In other cells
and tissues activin regulated the expression and bioactivity
of ECM components (Caniggia et al., 1997; Ogawa et al.,
2000), although it is not clear whether ECM remodeling is
associated with activin ligand bioactivity during branching
morphogenesis. Factors that degrade the basement mem-
brane had effects similar to those described when activin A
was exogenously added to salivary gland explants (Banerjee
et al., 1977; Nakanishi et al., 1986). Branching morphogen-
esis also depends on cell–ECM and epithelial cell–cell
adhesion. Integrins are expressed by many cell types in
branched organs and commonly mediate cell–ECM adhe-
sion in morphogenesis (reviewed in Pohl et al., 2000b). In
other systems, activin A played a role in cell adhesion
during development (Whittaker and DeSimone, 1993;
Ramos et al., 1996), but it is not clear whether activins have
similar effects during branching. Further studies using
three-dimensional gel matrices could examine the effect of
activin on branching in vitro, and particularly on the
expression and activity of ECM components and adhesion
molecules. Such systems could screen for factors that
modify branching by regulating activin ligands and identify
effectors of activin action.
A molecular description of branching morphogenesis is
lacking both overall and in specific organs. To date, this has
genesis and a proposed model for the role of activin. This simple
nching morphogenesis. Specifically it proposes that the epithelial
p. Branching commences with cleft formation in the mesenchymal
xpression and bioactivity may be modulated by factors such as
c acid (RA), and follistatin. This in turn leads to either branching
gree and location of activin signaling. The ECM remodeling may
ion of factors such as Sonic hedgehog.rpho
n bra
a ca
vin e
tinoi
e dehampered the identification of regulators and effectors of
s of reproduction in any form reserved.
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8 Ball and Risbridgeractivin action during branching. In the near future, the
fields of proteomics and genomics, coupled with techniques
such as laser capture microdissection, will have a substan-
tial impact on the characterization of factors involved in
branching. For example, detailed profiling of gene expres-
sion will identify differentially regulated genes in microdis-
sected epithelium versus mesenchyme in a particular or-
gan. Further, these techniques will allow a comparison of
analogous cell compartments across different branched or-
gans. Factors responsible for generating characteristics
common to all branching organs, as well as those respon-
sible for giving a specific organ its unique morphology and
function, may be identified. Thus, the contribution of
activins to these processes can be documented. Detailed
studies of the localization and expression of the full range of
activin subunits and related proteins are required, in the
examination of complex cell–cell interactions. In vitro
tudies should focus on dissecting the direct and indirect
ffects of activin signaling in branching morphogenesis by
dentifying downstream effectors of activin action and
athways with which activin signaling cross-talks. A de-
ailed analysis of genes both regulating and regulated by
ctivins is essential to reveal the role of activins in branch-
ng morphogenesis.
The studies that showed that activin A stimulates
ranching in the lung posed an interesting anomaly to our
eneral concept that activin A inhibits branching morpho-
enesis and raised several questions concerning the inter-
ction and/or redundancy between activins and other li-
ands. It was not possible to identify a common bioactivity
or a particular ligand that was the same for all branched
rgans; for example, a global inhibition of branching by
ctivin A or global stimulation of branching by TGFb. Nor
was it possible to show that the TGFb family members had
the same action in a particular branched organ; for example,
a global stimulation of branching morphogenesis in the
lung given that activin A and BMP-4 stimulated branching
but TGFb1, -b2, and -b3 were inhibitory (Kaartinen et al.,
1995; Zhou et al., 1996; Weaver et al., 1999; Liu et al., 2000;
Shi et al., 2001). Irrespective of the different bioactivities of
the ligands in the separate organs, any attempts to simplify
the data were further complicated by studying the down-
stream signaling effectors, for example, Smads. In the lung,
exogenously added activin A and TGFb1 had oppo-
ite effects but signal through common Smad proteins
Smad-2, -3, -4). When these Smads were blocked by anti-
ense oligonucleotides, branching was stimulated, implying
hat the composite effect of endogenous TGFb family
embers was inhibitory (Zhao et al., 1998).
Several members of the TGFb superfamily, including
ctivin A, were expressed in branched organs. However, the
elative levels of expression of the individual ligands and
heir relative bioactivities are unknown. No comparisons
bout the relative effects of ligands were reported in any
iven system. For example, BMP-2, -4, and -7, activin A, and
GFb are all expressed in the kidney but it is not knownwhich of these ligands has the most potent bioactivity
Copyright © 2001 by Academic Press. All right(Ritvos et al., 1995; Piscione et al., 1997; Miyazaki et al.,
2000; reviewed in Davies and Davey, 1999). A further
complication to comparisons such as these is the consider-
ation that branching is a dynamic process that occurs over
a period of time. At any point in the process, one member of
the TGFb family may be more important than another but
his may not be related to the developmental stage of the
rgan as a whole. Rather, the presence of several genera-
ions of branches and the spatial organization of the organ
ight result in a particular ligand being important in
aintaining duct length between secondary and tertiary
ranches, whereas other ligands might be responsible for
etermining the angle of the branchpoints, point of cleft
ormation, and so on. For example, in vitro activin A and
GFb are inhibitory in a number of organs but activin A
nhibited ductal branch formation and elongation, whereas
GFb inhibited branching and not elongation or tubulogen-
sis (Ritvos et al., 1995; Sakurai and Nigam, 1997; Chinoy
t al., 1998; Liu et al., 2000). Therefore any analysis of the
nteraction and redundancy between activins and other
igands requires consideration of the temporal, develop-
ental, and spatial organization of the organ that is under-
oing branching and the exact role that each ligand has in
hat process.
Overall, the studies presented in this review provide
ufficient evidence to conclude that activins have func-
ional roles in branching morphogenesis. Future studies to
etermine the roles of any of the TGFb-superfamily ligands
will require consideration of the activins. How the activins
perform their roles relative to each other and members of
the TGFb superfamily represents a significant challenge for
investigators in this field.
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